Sg3 Management, LLC Alector, Inc. Transaction History
Sg3 Management, LLC
- $0
- Q3 2023
A detailed history of Sg3 Management, LLC transactions in Alector, Inc. stock. As of the latest transaction made, Sg3 Management, LLC holds 10,000 shares of ALEC stock, worth $18,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$18,000% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ALEC
# of Institutions
167Shares Held
57.8MCall Options Held
146KPut Options Held
90.8K-
Black Rock Inc. New York, NY9.1MShares$16.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.46MShares$9.82 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.63MShares$8.34 Million0.8% of portfolio
-
Morgan Stanley New York, NY4.36MShares$7.84 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.73MShares$4.91 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $149M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...